What is the Generic Drugs Market?

The generic drugs market refers to the segment of the pharmaceutical industry that produces medications which are chemically identical to brand-name drugs, but are typically sold at lower prices once the patent protection for the original drug expires.

How big is the Generic Drugs Market?

The global Generic Drugs Market size was estimated at USD 424.2 Billion in 2023 and is expected to reach USD 691 Billion in 2033.

What is the Generic Drugs Market growth?

The global Generic Drugs Market is expected to grow at a compound annual growth rate of 5.0%. From 2024 To 2033

Who are the key companies/players in the Generic Drugs Market?

Some of the key players in the Generic Drugs Markets are Teva Pharmaceuticals, Sandoz, Viatris, Sun Pharma, Cipla, Dr. Reddy’s Laboratories, and Other Key Players.

Why are Generic Drugs Important?

Generic drugs play a crucial role in providing affordable healthcare solutions. They offer cost-effective alternatives to brand-name medications, making essential treatments more accessible to patients and healthcare systems worldwide.

What Drives the Growth of the Generic Drugs Market?

Several factors contribute to the growth of the generic drugs market, including patent expirations of brand-name drugs, increasing demand for affordable healthcare, government initiatives to promote generic drug usage, and advancements in generic drug manufacturing technologies.

What is the Future Outlook for the Generic Drugs Market?

Despite challenges, the generic drugs market is expected to continue its growth trajectory, driven by increasing demand for affordable medications, expanding healthcare access in developing countries, and ongoing efforts to streamline regulatory processes and ensure product quality and safety.

Generic Drugs Market By Therapeutic Area (Cardiovascular Diseases, Oncology, Central Nervous System Disorders, Respiratory Diseases, Other Drug Classes), By Route of Administration (Oral, Topical, Parenteral, Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Published date: April 2024
Report ID: 118335
Number of Pages: 249
Format:

Table of Contents
- 1. Executive Summary
  - 1.1. Definition
  - 1.2. Market Snapshot
  - 1.3. Market Overview
  - 1.4. Segment Overview
  - 1.5. Regional Overview
  - 1.6. Competitive Landscape
  - 1.7. Taxonomy
- 2. Global Market Overview
  - 2.1. Global Market Insights and Industry Overview
  - 2.2. Market Dynamics
    
    2.2.1. Drivers
    
    2.2.2. Restraints
    
    2.2.3. Opportunities
    
    2.2.4. Key Generic Drugs Market Trends
  - 2.3. Regulatory Framework
  - 2.4. Opportunity Map Analysis
  - 2.5. Opportunity Orbits
  - 2.6. PESTLE Analysis
  - 2.7. PORTER’S Five Force Analysis
  - 2.8. Drivers & Restraints Impact Analysis
  - 2.9. Value Chain Analysis
    
    2.9.1. List of Raw Materials Suppliers
    
    2.9.2. List of Generic Drugs Manufacturers
    
    2.9.3. List of Dealer/Distributors
  - 2.10. Regional Market Share and BPS Analysis
  - 2.11. Impact of Macro-economic Factors/Geopolitical Factors
- 3. Global Generic Drugs Market Analysis and Forecast, By Segment, 2018-2033
  - 3.1. Key Findings
  - 3.2. Global Generic Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Therapeutic Area, 2018-2033
  - 3.3. Global Generic Drugs Market Attractiveness Analysis, By Therapeutic Area
    
    3.3.1. Cardiovascular Diseases
    
    3.3.1.1. Insights
    
    3.3.1.2. Key Takeaways
    
    3.3.2. Oncology
    
    3.3.2.1. Insights
    
    3.3.2.2. Key Takeaways
    
    3.3.3. Central Nervous System Disorders
    
    3.3.3.1. Insights
    
    3.3.3.2. Key Takeaways
    
    3.3.4. Respiratory Diseases
    
    3.3.4.1. Insights
    
    3.3.4.2. Key Takeaways
    
    3.3.5. Other Therapeutic Areas
    
    3.3.5.1. Insights
    
    3.3.5.2. Key Takeaways
  - 3.4. Global Generic Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2018-2033
  - 3.5. Global Generic Drugs Market Attractiveness Analysis, By Route of Administration
    
    3.5.1. Oral
    
    3.5.1.1. Insights
    
    3.5.1.2. Key Takeaways
    
    3.5.2. Topical
    
    3.5.2.1. Insights
    
    3.5.2.2. Key Takeaways
    
    3.5.3. Parenteral
    
    3.5.3.1. Insights
    
    3.5.3.2. Key Takeaways
    
    3.5.4. Other Routes of Administration
    
    3.5.4.1. Insights
    
    3.5.4.2. Key Takeaways
  - 3.6. Global Generic Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2018-2033
  - 3.7. Global Generic Drugs Market Attractiveness Analysis, By Distribution Channel
    
    3.7.1. Retail Pharmacies
    
    3.7.1.1. Insights
    
    3.7.1.2. Key Takeaways
    
    3.7.2. Hospital Pharmacies
    
    3.7.2.1. Insights
    
    3.7.2.2. Key Takeaways
    
    3.7.3. Online Pharmacies
    
    3.7.3.1. Insights
    
    3.7.3.2. Key Takeaways
- 4. Global Generic Drugs Market Analysis and Forecast, By Region, 2018-2033
  - 4.1. Key Findings
  - 4.2. Global Generic Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2018-2033
    
    4.2.1. North America
    
    4.2.1.1. Regional Insights
    
    4.2.2. Europe
    
    4.2.2.1. Regional Insights
    
    4.2.3. Asia Pacific
    
    4.2.3.1. Regional Insights
    
    4.2.4. Latin America
    
    4.2.4.1. Regional Insights
    
    4.2.5. Middle East & Africa
    
    4.2.5.1. Regional Insights
  - 4.3. Global Generic Drugs Market Attractiveness Analysis, By Region
- 5. North America Generic Drugs Market Analysis and Forecast, 2018-2033
  - 5.1. Key Findings
  - 5.2. North America Generic Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Therapeutic Area, 2018-2033
  - 5.3. North America Generic Drugs Market Attractiveness Analysis, By Therapeutic Area
  - 5.4. North America Generic Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2018-2033
  - 5.5. North America Generic Drugs Market Attractiveness Analysis, By Route of Administration
  - 5.6. North America Generic Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2018-2033
  - 5.7. North America Generic Drugs Market Attractiveness Analysis, By Distribution Channel
  - 5.8. North America Generic Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2018-2033
  - 5.9. North America Generic Drugs Market Attractiveness Analysis, By Country
    
    5.9.1. The US
    
    5.9.2. Canada
  - 6. Europe Generic Drugs Market Analysis and Forecast, 2018-2033
  - 6.1. Key Findings
  - 6.2. Europe Generic Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Therapeutic Area, 2018-2033
  - 6.3. Europe Generic Drugs Market Attractiveness Analysis, By Therapeutic Area
  - 6.4. Europe Generic Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2018-2033
  - 6.5. Europe Generic Drugs Market Attractiveness Analysis, By Route of Administration
  - 6.6. Europe Generic Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2018-2033
  - 6.7. Europe Generic Drugs Market Attractiveness Analysis, By Distribution Channel
  - 6.8. Europe Generic Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2018-2033
  - 6.9. Europe Generic Drugs Market Attractiveness Analysis, By Country
    
    6.9.1. Germany
    
    6.9.2. The UK
    
    6.9.3. France
    
    6.9.4. Spain
    
    6.9.5. Italy
    
    6.9.6. Russia
    
    6.9.7. Netherlands
    
    6.9.8. Rest of Europe
- 7. Asia Pacific Generic Drugs Market Analysis and Forecast, 2018-2033
  - 7.1. Key Findings
  - 7.2. Asia Pacific Generic Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Therapeutic Area, 2018-2033
  - 7.3. Asia Pacific Generic Drugs Market Attractiveness Analysis, By Therapeutic Area
  - 7.4. Asia Pacific Generic Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2018-2033
  - 7.5. Asia Pacific Generic Drugs Market Attractiveness Analysis, By Route of Administration
  - 7.6. Asia Pacific Generic Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2018-2033
  - 7.7. Asia Pacific Generic Drugs Market Attractiveness Analysis, By Distribution Channel
  - 7.8. Asia Pacific Generic Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2018-2033
  - 7.9. Asia Pacific Generic Drugs Market Attractiveness Analysis, By Country
    
    7.9.1. China
    
    7.9.2. Japan
    
    7.9.3. South Korea
    
    7.9.4. India
    
    7.9.5. New Zealand
    
    7.9.6. Singapore
    
    7.9.7. Thailand
    
    7.9.8. Vietnam
    
    7.9.9. Rest of Asia Pacific
- 8. Latin America Generic Drugs Market Analysis and Forecast, 2018-2033
  - 8.1. Key Findings
  - 8.2. Latin America Generic Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Therapeutic Area, 2018-2033
  - 8.3. Latin America Generic Drugs Market Attractiveness Analysis, By Therapeutic Area
  - 8.4. Latin America Generic Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2018-2033
  - 8.5. Latin America Generic Drugs Market Attractiveness Analysis, By Route of Administration
  - 8.6. Latin America Generic Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2018-2033
  - 8.7. Latin America Generic Drugs Market Attractiveness Analysis, By Distribution Channel
  - 8.8. Latin America Generic Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2018-2033
  - 8.9. Latin America Generic Drugs Market Attractiveness Analysis, By Country
    
    8.9.1. Brazil
    
    8.9.2. Mexico
    
    8.9.3. Rest of Latin America
- 9. Middle East & Africa Generic Drugs Market Analysis and Forecast, 2018-2033
  - 9.1. Key Findings
  - 9.2. Middle East & Africa Generic Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Therapeutic Area, 2018-2033
  - 9.3. Middle East & Africa Generic Drugs Market Attractiveness Analysis, By Therapeutic Area
  - 9.4. Middle East & Africa Generic Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2018-2033
  - 9.5. Middle East & Africa Generic Drugs Market Attractiveness Analysis, By Route of Administration
  - 9.6. Middle East & Africa Generic Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2018-2033
  - 9.7. Middle East & Africa Generic Drugs Market Attractiveness Analysis, By Distribution Channel
  - 9.8. Middle East & Africa Generic Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2018-2033
  - 9.9. Middle East & Africa Generic Drugs Market Attractiveness Analysis, By Country
    
    9.9.1. South Africa
    
    9.9.2. Saudi Arabia
    
    9.9.3. UAE
    
    9.9.4. Rest of Middle East & Africa
- 10. Competitive Landscape & Company Profiles
  - 10.1. Market Competition Scenario Analysis, By Company
    
    10.1.1. Key Takeaways
  - 10.2. Overview of Major Market Players
  - 10.3. Competitor Landscape
  - 10.4. Strategic Mapping
  - 10.5. Company Life Cycle Analysis
  - 10.6. Company Market Share Analysis
  - 10.7. Company Profiles
    
    10.7.1. Teva Pharmaceuticals
    
    10.7.1.1. Company Details
    
    10.7.1.2. Business Overview
    
    10.7.1.3. Therapeutic Area Portfolio
    
    10.7.1.4. Financial Insights
    
    10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Therapeutic Area Development)
    
    10.7.1.6. SWOT Analysis
    
    10.7.1.7. Geographic Footprint
    
    10.7.2. Sandoz
    
    10.7.2.1. Company Details
    
    10.7.2.2. Business Overview
    
    10.7.2.3. Therapeutic Area Portfolio
    
    10.7.2.4. Financial Insights
    
    10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Therapeutic Area Development)
    
    10.7.2.6. SWOT Analysis
    
    10.7.2.7. Geographic Footprint
    
    10.7.3. Viatris
    
    10.7.3.1. Company Details
    
    10.7.3.2. Business Overview
    
    10.7.3.3. Therapeutic Area Portfolio
    
    10.7.3.4. Financial Insights
    
    10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Therapeutic Area Development)
    
    10.7.3.6. SWOT Analysis
    
    10.7.3.7. Geographic Footprint
    
    10.7.4. Sun Pharma
    
    10.7.4.1. Company Details
    
    10.7.4.2. Business Overview
    
    10.7.4.3. Therapeutic Area Portfolio
    
    10.7.4.4. Financial Insights
    
    10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Therapeutic Area Development)
    
    10.7.4.6. SWOT Analysis
    
    10.7.4.7. Geographic Footprint
    
    10.7.5. Cipla
    
    10.7.5.1. Company Details
    
    10.7.5.2. Business Overview
    
    10.7.5.3. Therapeutic Area Portfolio
    
    10.7.5.4. Financial Insights
    
    10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Therapeutic Area Development)
    
    10.7.5.6. SWOT Analysis
    
    10.7.5.7. Geographic Footprint
    
    10.7.6. Dr. Reddy’s Laboratories
    
    10.7.6.1. Company Details
    
    10.7.6.2. Business Overview
    
    10.7.6.3. Therapeutic Area Portfolio
    
    10.7.6.4. Financial Insights
    
    10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Therapeutic Area Development)
    
    10.7.6.6. SWOT Analysis
    
    10.7.6.7. Geographic Footprint
    
    10.7.7. Other Key Players
    
    10.7.7.1. Company Details
    
    10.7.7.2. Business Overview
    
    10.7.7.3. Therapeutic Area Portfolio
    
    10.7.7.4. Financial Insights
    
    10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Therapeutic Area Development)
    
    10.7.7.6. SWOT Analysis
    
    10.7.7.7. Geographic Footprint
- 11. Methodology and Data Source
  - 11.1. Methodology/Research Approach
  - 11.2. Market Size Estimation
  - 11.3. Market Breakdown and Data Triangulation
  - 11.4. Data Source
  - 11.5. Secondary Sources
  - 11.6. Primary Sources
  - 11.7. Appendix
  - 11.8. Disclaimer
List of Tables
- Table 1. Global Generic Drugs Market Value (US$ Mn), By Therapeutic Area, 2018-2033
- Table 2. Global Generic Drugs Market Value (US$ Mn), By Route of Administration, 2018-2033
- Table 3. Global Generic Drugs Market Value (US$ Mn), By Distribution Channel, 2018-2033
- Table 4. Global Generic Drugs Market Value (US$ Mn), By Region, 2018-2033
- Table 5. North America Generic Drugs Market Value (US$ Mn), By Therapeutic Area, 2018-2033
- Table 6. North America Generic Drugs Market Value (US$ Mn), By Route of Administration, 2018-2033
- Table 7. North America Generic Drugs Market Value (US$ Mn), By Distribution Channel, 2018-2033
- Table 8. North America Generic Drugs Market Value (US$ Mn), By Country, 2018-2033
- Table 9. The US Generic Drugs Market Value (US$ Mn), By Therapeutic Area, 2018-2033
- Table 10. The US Generic Drugs Market Value (US$ Mn), By Route of Administration, 2018-2033
- Table 11. The US Generic Drugs Market Value (US$ Mn), By Distribution Channel, 2018-2033
- Table 12. Canada Generic Drugs Market Value (US$ Mn), By Therapeutic Area, 2018-2033
- Table 13. Canada Generic Drugs Market Value (US$ Mn), By Route of Administration, 2018-2033
- Table 14. Canada Generic Drugs Market Value (US$ Mn), By Distribution Channel, 2018-2033
- Table 15. Europe Generic Drugs Market Value (US$ Mn), By Therapeutic Area, 2018-2033
- Table 16. Europe Generic Drugs Market Value (US$ Mn), By Route of Administration, 2018-2033
- Table 17. Europe Generic Drugs Market Value (US$ Mn), By Distribution Channel, 2018-2033
- Table 18. Europe Generic Drugs Market Value (US$ Mn), By Country, 2018-2033
- Table 19. Germany Generic Drugs Market Value (US$ Mn), By Therapeutic Area, 2018-2033
- Table 20. Germany Generic Drugs Market Value (US$ Mn), By Route of Administration, 2018-2033
- Table 21. Germany Generic Drugs Market Value (US$ Mn), By Distribution Channel, 2018-2033
- Table 22. The UK Generic Drugs Market Value (US$ Mn), By Therapeutic Area, 2018-2033
- Table 23. The UK Generic Drugs Market Value (US$ Mn), By Route of Administration, 2018-2033
- Table 24. The UK Generic Drugs Market Value (US$ Mn), By Distribution Channel, 2018-2033
- Table 25. France Generic Drugs Market Value (US$ Mn), By Therapeutic Area, 2018-2033
- Table 26. France Generic Drugs Market Value (US$ Mn), By Route of Administration, 2018-2033
- Table 27. France Generic Drugs Market Value (US$ Mn), By Distribution Channel, 2018-2033
- Table 28. Spain Generic Drugs Market Value (US$ Mn), By Therapeutic Area, 2018-2033
- Table 29. Spain Generic Drugs Market Value (US$ Mn), By Route of Administration, 2018-2033
- Table 30. Spain Generic Drugs Market Value (US$ Mn), By Distribution Channel, 2018-2033
- Table 31. Italy Generic Drugs Market Value (US$ Mn), By Therapeutic Area, 2018-2033
- Table 32. Italy Generic Drugs Market Value (US$ Mn), By Route of Administration, 2018-2033
- Table 33. Italy Generic Drugs Market Value (US$ Mn), By Distribution Channel, 2018-2033
- Table 34. Russia Generic Drugs Market Value (US$ Mn), By Therapeutic Area, 2018-2033
- Table 35. Russia Generic Drugs Market Value (US$ Mn), By Route of Administration, 2018-2033
- Table 36. Russia Generic Drugs Market Value (US$ Mn), By Distribution Channel, 2018-2033
- Table 37. Netherlands Generic Drugs Market Value (US$ Mn), By Therapeutic Area, 2018-2033
- Table 38. Netherlands Generic Drugs Market Value (US$ Mn), By Route of Administration, 2018-2033
- Table 39. Netherlands Generic Drugs Market Value (US$ Mn), By Distribution Channel, 2018-2033
- Table 40. Rest of Europe Generic Drugs Market Value (US$ Mn), By Therapeutic Area, 2018-2033
- Table 41. Rest of Europe Generic Drugs Market Value (US$ Mn), By Route of Administration, 2018-2033
- Table 42. Rest of Europe Generic Drugs Market Value (US$ Mn), By Distribution Channel, 2018-2033
- Table 43. Asia Pacific Generic Drugs Market Value (US$ Mn), By Therapeutic Area, 2018-2033
- Table 44. Asia Pacific Generic Drugs Market Value (US$ Mn), By Route of Administration, 2018-2033
- Table 45. Asia Pacific Generic Drugs Market Value (US$ Mn), By Distribution Channel, 2018-2033
- Table 46. Asia Pacific Generic Drugs Market Value (US$ Mn), By Country, 2018-2033
- Table 47. China Generic Drugs Market Value (US$ Mn), By Therapeutic Area, 2018-2033
- Table 48. China Generic Drugs Market Value (US$ Mn), By Route of Administration, 2018-2033
- Table 49. China Generic Drugs Market Value (US$ Mn), By Distribution Channel, 2018-2033
- Table 50. India Generic Drugs Market Value (US$ Mn), By Therapeutic Area, 2018-2033
- Table 51. Global Generic Drugs Market Value (US$ Mn), By Route of Administration, 2018-2033
- Table 52. Global Generic Drugs Market Value (US$ Mn), By Distribution Channel, 2018-2033
- Table 53. Japan Generic Drugs Market Value (US$ Mn), By Therapeutic Area, 2018-2033
- Table 54. Japan Generic Drugs Market Value (US$ Mn), By Route of Administration, 2018-2033
- Table 55. Japan Generic Drugs Market Value (US$ Mn), By Distribution Channel, 2018-2033
- Table 56. South Korea Generic Drugs Market Value (US$ Mn), By Therapeutic Area, 2018-2033
- Table 57. South Korea Generic Drugs Market Value (US$ Mn), By Route of Administration, 2018-2033
- Table 58. South Korea Generic Drugs Market Value (US$ Mn), By Distribution Channel, 2018-2033
- Table 59. New Zealand Generic Drugs Market Value (US$ Mn), By Therapeutic Area, 2018-2033
- Table 60. New Zealand Generic Drugs Market Value (US$ Mn), By Route of Administration, 2018-2033
- Table 61. New Zealand Generic Drugs Market Value (US$ Mn), By Distribution Channel, 2018-2033
- Table 62. Singapore Generic Drugs Market Value (US$ Mn), By Therapeutic Area, 2018-2033
- Table 63. Singapore Generic Drugs Market Value (US$ Mn), By Route of Administration, 2018-2033
- Table 64. Singapore Generic Drugs Market Value (US$ Mn), By Distribution Channel, 2018-2033
- Table 65. Thailand Generic Drugs Market Value (US$ Mn), By Therapeutic Area, 2018-2033
- Table 66. Thailand Generic Drugs Market Value (US$ Mn), By Route of Administration, 2018-2033
- Table 67. Thailand Generic Drugs Market Value (US$ Mn), By Distribution Channel, 2018-2033
- Table 68. Vietnam Generic Drugs Market Value (US$ Mn), By Therapeutic Area, 2018-2033
- Table 69. Vietnam Generic Drugs Market Value (US$ Mn), By Route of Administration, 2018-2033
- Table 70. Vietnam Generic Drugs Market Value (US$ Mn), By Distribution Channel, 2018-2033
- Table 71. Rest of Asia Pacific Generic Drugs Market Value (US$ Mn), By Therapeutic Area, 2018-2033
- Table 72. Rest of Asia Pacific Generic Drugs Market Value (US$ Mn), By Route of Administration, 2018-2033
- Table 73. Rest of Asia Pacific Generic Drugs Market Value (US$ Mn), By Distribution Channel, 2018-2033
- Table 74. Latin America Generic Drugs Market Value (US$ Mn), By Therapeutic Area, 2018-2033
- Table 75. Latin America Generic Drugs Market Value (US$ Mn), By Route of Administration, 2018-2033
- Table 76. Latin America Generic Drugs Market Value (US$ Mn), By Distribution Channel, 2018-2033
- Table 77. Latin America Generic Drugs Market Value (US$ Mn), By Country, 2018-2033
- Table 78. Brazil Generic Drugs Market Value (US$ Mn), By Therapeutic Area, 2018-2033
- Table 79. Brazil Generic Drugs Market Value (US$ Mn), By Route of Administration, 2018-2033
- Table 80. Brazil Generic Drugs Market Value (US$ Mn), By Distribution Channel, 2018-2033
- Table 81. Mexico Generic Drugs Market Value (US$ Mn), By Therapeutic Area, 2018-2033
- Table 82. Mexico Generic Drugs Market Value (US$ Mn), By Route of Administration, 2018-2033
- Table 83. Mexico Generic Drugs Market Value (US$ Mn), By Distribution Channel, 2018-2033
- Table 84. Rest of Latin America Generic Drugs Market Value (US$ Mn), By Therapeutic Area, 2018-2033
- Table 85. Rest of Latin America Generic Drugs Market Value (US$ Mn), By Route of Administration, 2018-2033
- Table 86. Rest of Latin America Generic Drugs Market Value (US$ Mn), By Distribution Channel, 2018-2033
- Table 87. Middle East & Africa Generic Drugs Market Value (US$ Mn), By Therapeutic Area, 2018-2033
- Table 88. Middle East & Africa Generic Drugs Market Value (US$ Mn), By Route of Administration, 2018-2033
- Table 89. Middle East & Africa Generic Drugs Market Value (US$ Mn), By Distribution Channel, 2018-2033
- Table 90. Middle East & Africa Generic Drugs Market Value (US$ Mn), By Country, 2018-2033
- Table 91. South Africa Generic Drugs Market Value (US$ Mn), By Therapeutic Area, 2018-2033
- Table 92. South Africa Generic Drugs Market Value (US$ Mn), By Route of Administration, 2018-2033
- Table 93. South Africa Generic Drugs Market Value (US$ Mn), By Distribution Channel, 2018-2033
- Table 94. Saudi Arabia Generic Drugs Market Value (US$ Mn), By Therapeutic Area, 2018-2033
- Table 95. Saudi Arabia Generic Drugs Market Value (US$ Mn), By Route of Administration, 2018-2033
- Table 96. Saudi Arabia Generic Drugs Market Value (US$ Mn), By Distribution Channel, 2018-2033
- Table 97. UAE Generic Drugs Market Value (US$ Mn), By Therapeutic Area, 2018-2033
- Table 98. UAE Generic Drugs Market Value (US$ Mn), By Route of Administration, 2018-2033
- Table 99. UAE Generic Drugs Market Value (US$ Mn), By Distribution Channel, 2018-2033
- Table 100. Rest of Middle East & Africa Generic Drugs Market Value (US$ Mn), By Therapeutic Area, 2018-2033
- Table 101. Rest of Middle East & Africa Generic Drugs Market Value (US$ Mn), By Route of Administration, 2018-2033
- Table 102. Rest of Middle East & Africa Generic Drugs Market Value (US$ Mn), By Distribution Channel, 2018-2033
List of Figures
- Figure 1. Global Generic Drugs Market Snapshot: Market Value (US$ Mn), 2018-2033
- Figure 2. Opportunity Map
- Figure 3. Opportunity Orbit
- Figure 4. Regional Market Share and BPS Analysis in Generic Drugs Market
- Figure 5. Global Generic Drugs Market Analysis, By Therapeutic Area, 2018, 2022 and 2033
- Figure 6. Global Generic Drugs Market Attractiveness Analysis, By Therapeutic Area
- Figure 7. Global Generic Drugs Market Analysis, By Route of Administration, 2018, 2022 and 2033
- Figure 8. Global Generic Drugs Market Attractiveness Analysis, By Route of Administration
- Figure 9. Global Generic Drugs Market Analysis, By Distribution Channel, 2018, 2022 and 2033
- Figure 10. Global Generic Drugs Market Attractiveness Analysis, By Distribution Channel
- Figure 11. North America Generic Drugs Market Analysis, By Therapeutic Area, 2018, 2022 and 2033
- Figure 12. North America Generic Drugs Market Attractiveness Analysis, By Therapeutic Area
- Figure 13. North America Generic Drugs Market (US$ Mn), by Cardiovascular Diseases, 2018-2033
- Figure 14. North America Generic Drugs Market (US$ Mn), by Oncology, 2018-2033
- Figure 15. North America Generic Drugs Market (US$ Mn), by Central Nervous System Disorders, 2018-2033
- Figure 16. North America Generic Drugs Market (US$ Mn), by Respiratory Diseases, 2018-2033
- Figure 17. North America Generic Drugs Market (US$ Mn), by Other Therapeutic Areas, 2018-2033
- Figure 18. North America Generic Drugs Market Analysis, By Route of Administration, 2018, 2022 and 2033
- Figure 19. North America Generic Drugs Market Attractiveness Analysis, By Route of Administration
- Figure 20. North America Generic Drugs Market (US$ Mn), by Oral, 2018-2033
- Figure 21. North America Generic Drugs Market (US$ Mn), by Topical, 2018-2033
- Figure 22. North America Generic Drugs Market (US$ Mn), by Parenteral, 2018-2033
- Figure 23. North America Generic Drugs Market (US$ Mn), by Other Routes of Administration, 2018-2033
- Figure 24. North America Generic Drugs Market Analysis, By Distribution Channel, 2018, 2022 and 2033
- Figure 25. North America Generic Drugs Market Attractiveness Analysis, By Distribution Channel
- Figure 26. North America Generic Drugs Market (US$ Mn), by Retail Pharmacies, 2018-2033
- Figure 27. North America Generic Drugs Market (US$ Mn), by Hospital Pharmacies, 2018-2033
- Figure 28. North America Generic Drugs Market (US$ Mn), by Online Pharmacies, 2018-2033
- Figure 29. North America Generic Drugs Market Analysis, By Country, 2018, 2022 and 2033
- Figure 30. North America Generic Drugs Market Attractiveness Analysis, By Country
- Figure 31. Europe Generic Drugs Market Analysis, By Therapeutic Area, 2018, 2022 and 2033
- Figure 32. Europe Generic Drugs Market Attractiveness Analysis, By Therapeutic Area
- Figure 33. Europe Generic Drugs Market (US$ Mn), by Cardiovascular Diseases, 2018-2033
- Figure 34. Europe Generic Drugs Market (US$ Mn), by Oncology, 2018-2033
- Figure 35. Europe Generic Drugs Market (US$ Mn), by Central Nervous System Disorders, 2018-2033
- Figure 36. Europe Generic Drugs Market (US$ Mn), by Respiratory Diseases, 2018-2033
- Figure 37. Europe Generic Drugs Market (US$ Mn), by Other Therapeutic Areas, 2018-2033
- Figure 38. Europe Generic Drugs Market Analysis, By Route of Administration, 2018, 2022 and 2033
- Figure 39. Europe Generic Drugs Market Attractiveness Analysis, By Route of Administration
- Figure 40. Europe Generic Drugs Market (US$ Mn), by Oral, 2018-2033
- Figure 41. Europe Generic Drugs Market (US$ Mn), by Topical, 2018-2033
- Figure 42. Europe Generic Drugs Market (US$ Mn), by Parenteral, 2018-2033
- Figure 43. Europe Generic Drugs Market (US$ Mn), by Other Routes of Administration, 2018-2033
- Figure 44. Europe Generic Drugs Market Analysis, By Distribution Channel, 2018, 2022 and 2033
- Figure 45. Europe Generic Drugs Market Attractiveness Analysis, By Distribution Channel
- Figure 46. Europe Generic Drugs Market (US$ Mn), by Retail Pharmacies, 2018-2033
- Figure 47. Europe Generic Drugs Market (US$ Mn), by Hospital Pharmacies, 2018-2033
- Figure 48. Europe Generic Drugs Market (US$ Mn), by Online Pharmacies, 2018-2033
- Figure 49. Europe Generic Drugs Market Analysis, By Country, 2018, 2022 and 2033
- Figure 50. Europe Generic Drugs Market Attractiveness Analysis, By Country
- Figure 51. Asia Pacific Generic Drugs Market Analysis, By Therapeutic Area, 2018, 2022 and 2033
- Figure 52. Asia Pacific Generic Drugs Market Attractiveness Analysis, By Therapeutic Area
- Figure 53. Asia Pacific Generic Drugs Market (US$ Mn), by Cardiovascular Diseases, 2018-2033
- Figure 54. Asia Pacific Generic Drugs Market (US$ Mn), by Oncology, 2018-2033
- Figure 55. Asia Pacific Generic Drugs Market (US$ Mn), by Central Nervous System Disorders, 2018-2033
- Figure 56. Asia Pacific Generic Drugs Market (US$ Mn), by Respiratory Diseases, 2018-2033
- Figure 57. Asia Pacific Generic Drugs Market (US$ Mn), by Other Therapeutic Areas, 2018-2033
- Figure 58. Asia Pacific Generic Drugs Market Analysis, By Route of Administration, 2018, 2022 and 2033
- Figure 59. Asia Pacific Generic Drugs Market Attractiveness Analysis, By Route of Administration
- Figure 60. Asia Pacific Generic Drugs Market (US$ Mn), by Oral, 2018-2033
- Figure 61. Asia Pacific Generic Drugs Market (US$ Mn), by Topical, 2018-2033
- Figure 62. Asia Pacific Generic Drugs Market (US$ Mn), by Parenteral, 2018-2033
- Figure 63. Asia Pacific Generic Drugs Market (US$ Mn), by Other Routes of Administration, 2018-2033
- Figure 64. Asia Pacific Generic Drugs Market Analysis, By Distribution Channel, 2018, 2022 and 2033
- Figure 65. Asia Pacific Generic Drugs Market Attractiveness Analysis, By Distribution Channel
- Figure 66. Asia Pacific Generic Drugs Market (US$ Mn), by Retail Pharmacies, 2018-2033
- Figure 67. Asia Pacific Generic Drugs Market (US$ Mn), by Hospital Pharmacies, 2018-2033
- Figure 68. Asia Pacific Generic Drugs Market (US$ Mn), by Online Pharmacies, 2018-2033
- Figure 69. Asia Pacific Generic Drugs Market Analysis, By Country, 2018, 2022 and 2033
- Figure 70. Asia Pacific Generic Drugs Market Attractiveness Analysis, By Country
- Figure 71. Latin America Generic Drugs Market Analysis, By Therapeutic Area, 2018, 2022 and 2033
- Figure 72. Latin America Generic Drugs Market Attractiveness Analysis, By Therapeutic Area
- Figure 73. Latin America Generic Drugs Market (US$ Mn), by Cardiovascular Diseases, 2018-2033
- Figure 74. Latin America Generic Drugs Market (US$ Mn), by Oncology, 2018-2033
- Figure 75. Latin America Generic Drugs Market (US$ Mn), by Central Nervous System Disorders, 2018-2033
- Figure 76. Latin America Generic Drugs Market (US$ Mn), by Respiratory Diseases, 2018-2033
- Figure 77. Latin America Generic Drugs Market (US$ Mn), by Other Therapeutic Areas, 2018-2033
- Figure 78. Latin America Generic Drugs Market Analysis, By Route of Administration, 2018, 2022 and 2033
- Figure 79. Latin America Generic Drugs Market Attractiveness Analysis, By Route of Administration
- Figure 80. Latin America Generic Drugs Market (US$ Mn), by Oral, 2018-2033
- Figure 81. Latin America Generic Drugs Market (US$ Mn), by Topical, 2018-2033
- Figure 82. Latin America Generic Drugs Market (US$ Mn), by Parenteral, 2018-2033
- Figure 83. Latin America Generic Drugs Market (US$ Mn), by Other Routes of Administration, 2018-2033
- Figure 84. Latin America Generic Drugs Market Analysis, By Distribution Channel, 2018, 2022 and 2033
- Figure 85. Latin America Generic Drugs Market Attractiveness Analysis, By Distribution Channel
- Figure 86. Latin America Generic Drugs Market (US$ Mn), by Retail Pharmacies, 2018-2033
- Figure 87. Latin America Generic Drugs Market (US$ Mn), by Hospital Pharmacies, 2018-2033
- Figure 88. Latin America Generic Drugs Market (US$ Mn), by Online Pharmacies, 2018-2033
- Figure 89. Latin America Generic Drugs Market Analysis, By Country, 2018, 2022 and 2033
- Figure 90. Latin America Generic Drugs Market Attractiveness Analysis, By Country
- Figure 91. Middle East & Africa Generic Drugs Market Analysis, By Therapeutic Area, 2018, 2022 and 2033
- Figure 92. Middle East & Africa Generic Drugs Market Attractiveness Analysis, By Therapeutic Area
- Figure 93. Middle East & Africa Generic Drugs Market (US$ Mn), by Cardiovascular Diseases, 2018-2033
- Figure 94. Middle East & Africa Generic Drugs Market (US$ Mn), by Oncology, 2018-2033
- Figure 95. Middle East & Africa Generic Drugs Market (US$ Mn), by Central Nervous System Disorders, 2018-2033
- Figure 96. Middle East & Africa Generic Drugs Market (US$ Mn), by Respiratory Diseases, 2018-2033
- Figure 97. Middle East & Africa Generic Drugs Market (US$ Mn), by Other Therapeutic Areas, 2018-2033
- Figure 98. Middle East & Africa Generic Drugs Market Analysis, By Route of Administration, 2018, 2022 and 2033
- Figure 99. Middle East & Africa Generic Drugs Market Attractiveness Analysis, By Route of Administration
- Figure 100. Middle East & Africa Generic Drugs Market (US$ Mn), by Oral, 2018-2033
- Figure 101. Middle East & Africa Generic Drugs Market (US$ Mn), by Topical, 2018-2033
- Figure 102. Middle East & Africa Generic Drugs Market (US$ Mn), by Parenteral, 2018-2033
- Figure 103. Middle East & Africa Generic Drugs Market (US$ Mn), by Other Routes of Administration, 2018-2033
- Figure 104. Middle East & Africa Generic Drugs Market Analysis, By Distribution Channel, 2018, 2022 and 2033
- Figure 105. Middle East & Africa Generic Drugs Market Attractiveness Analysis, By Distribution Channel
- Figure 106. Middle East & Africa Generic Drugs Market (US$ Mn), by Retail Pharmacies, 2018-2033
- Figure 107. Middle East & Africa Generic Drugs Market (US$ Mn), by Hospital Pharmacies, 2018-2033
- Figure 108. Middle East & Africa Generic Drugs Market (US$ Mn), by Online Pharmacies, 2018-2033
- Figure 109. Middle East & Africa Generic Drugs Market Analysis, By Country, 2018, 2022 and 2033
- Figure 110. Middle East & Africa Generic Drugs Market Attractiveness Analysis, By Country
- Teva Pharmaceuticals
- Sandoz
- Viatris
- Sun Pharma
- Cipla Limited Company Profile
- Dr. Reddys Laboratories Ltd Company Profile
- Other Key Players
Settings

Related Reports

Our Clients

Inquiry Before Buying

Report ID 118335
Published Date April 2024
Rating
- ★★★★★
  
  ★★★★★
- (30)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)

Table of Contents

List of Tables

List of Figures

Related Reports

Our Clients